Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2017 Sep 21;69(11):1651–1658. doi: 10.1002/acr.23208

Table 3.

Baseline chondrocalcinosis and knee pain (continuous measurement) at year 0 and year 4, and change of knee pain

CC at baseline Crude model Adjusted model*
mean (95% CI) p-value adjusted mean (95% CI) p-value
knee pain severity, past 30 days (0–10)
at year 0
CC− (n=2026) 2.3 (2.2,2.4) 0.04 2.0 (1.9,2.2) 0.02
CC+ (n=162) 2.8 (2.3,3.3) 2.6 (2.2,3.1)
at year 4
CC− (n=1895) 2.2 (2.1,2.4) 0.19 2.0 (1.8,2.1) 0.11
CC+ (n=151) 2.6 (2.1,3.1) 2.4 (1.9,2.9)
change from year 0 to year 4
CC− (n=1891) 0.0 (−0.2,0.1) 0.47 −0.1 (−0.2,0.1) 0.50
CC+ (n=151) −0.3 (−0.8,0.3) −0.3 (−0.9,0.3)

WOMAC knee pain subscale (0–20)
at year 0
CC− (n=2030) 2.1 (1.9,2.2) 0.08 1.8 (1.7,1.9) 0.03
CC+ (n=162) 2.6 (2.0,3.1) 2.4 (1.9,2.9)
at year 4
CC− (n=1898) 1.8 (1.7,2.0) 0.01 1.6 (1.5,1.8) <0.01
CC+ (n=151) 2.6 (2.0,3.2) 2.5 (1.9,3.1)
change from year 0 to year 4
CC− (n=1898) −0.2 (−0.3,0.0) 0.63 −0.1 (−0.3,0.0) 0.68
CC+ (n=151) 0.0 (−0.7,0.6) 0.0 (−0.6,0.6)
*

Adjusting for age, gender, BMI, and KL grade at baseline